The aberrant immune and epidermal response seen in psoriasis is maintained by pathogenic crosstalk between epithelial and immune cells, and it is primarily driven by proinflammatory molecules, such as TNF-α, IL-23 and IL-17. This evidence concerns the gene IL23A and psoriasis.